Danimer Scientific DNMR

$ 5.31 -4.67%

Quarterly report 2024-Q3
added 11-19-2024

Danimer Scientific Balance Sheet 2011-2024 | DNMR

Annual Balance Sheet Danimer Scientific

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	362 M	239 M	-11.8 M	-346 M	76.8 M	-	-	-	-	-	-	-	-
Long Term Debt	417 M	298 M	272 M	31.4 M	73.8 M	-	-	-	-	-	-	-	-
Long Term Debt Current	3.34 M	3.34 M	3.34 M	3 M	2.58 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	93.7 M	-	-	-	-	-	-	-	-
Total Current Liabilities	15.7 M	25.3 M	43.5 M	50.5 M	34.3 M	-	-	-	-	-	-	-	-
Total Liabilities	420 M	335 M	338 M	107 M	128 M	-	-	-	-	-	-	-	-
Deferred Revenue	1 M	-	214 K	2.46 M	4.58 M	-	-	-	-	-	-	-	-
Retained Earnings	-454 M	-299 M	-119 M	-62.5 M	-49.9 M	-	-	-	-	-	-	-	-
Total Assets	698 M	712 M	839 M	546 M	145 M	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	59.2 M	62.8 M	287 M	380 M	6.26 M	6.55 M	-	-	-	-	-	-	-
Book Value	278 M	378 M	500 M	439 M	16.6 M	-	-	-	-	-	-	-	-
Total Shareholders Equity	278 M	378 M	500 M	356 M	16.6 M	26.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Danimer Scientific

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	414 M	423 M	417 M	417 M	417 M	418 M	423 M	298 M	298 M	274 M	272 M	272 M	29.5 M	29.6 M	31.3 M	31.4 M	60.5 M	31.4 M	31.4 M	88.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	432 M	433 M	433 M	420 M	417 M	414 M	423 M	335 M	342 M	319 M	325 M	338 M	121 M	139 M	230 M	190 M	190 M	190 M	190 M	128 M	56.9 K	56.9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	914 K	850 K	1.15 M	1 M	-	-	-	-	2 M	2.29 M	-	214 K	233 K	822 K	2.34 M	2.46 M	2.46 M	2.46 M	2.46 M	4.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-526 M	-504 M	-481 M	-454 M	-415 M	-375 M	-335 M	-299 M	-271 M	-176 M	-145 M	-119 M	-106 M	-114 M	-154 M	-58.8 M	-58.8 M	-58.8 M	-58.8 M	-49.9 M	-3.98 K	-3.98 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	644 M	667 M	689 M	698 M	721 M	744 M	779 M	712 M	733 M	791 M	812 M	839 M	650 M	646 M	512 M	546 M	546 M	546 M	546 M	145 M	78 K	78 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	22.2 M	40.3 M	57.3 M	59.2 M	91.9 M	105 M	134 M	64.4 M	101 M	141 M	211 M	287 M	196 M	417 M	313 M	380 M	378 M	378 M	378 M	6.26 M	20 K	20 K	-	6.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	212 M	234 M	256 M	278 M	304 M	330 M	356 M	378 M	392 M	472 M	488 M	500 M	529 M	507 M	282 M	356 M	356 M	356 M	356 M	16.6 M	21 K	21 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	212 M	234 M	256 M	278 M	304 M	330 M	356 M	378 M	392 M	472 M	488 M	500 M	529 M	507 M	282 M	356 M	356 M	356 M	356 M	16.6 M	21 K	21 K	-	26.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency